Company profile
Tempest Therapeutics, Inc. Insider Trading
TPSTEvery SEC Form 4 insider trading filing for Tempest Therapeutics, Inc. (TPST) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001544227
- Filings
- 35
- Insiders
- 20
- Last filing
- 2026-06-04
Activity summary
No insider transactions in the last 30 days. The most recent was on June 4, 2026, when William Drake Richey bought 25,000 shares. 35 filings from 20 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q3 23 to Q2 26. Tempest Therapeutics, Inc. insiders are net buyers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.0M.
No insider activity recorded for TPST in the last 90 days.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | William Drake Richey | TPST | Award | 25,000 | — | — |
| Jun 4, 2026 | John D. Yee | TPST | Award | 25,000 | — | — |
| Mar 31, 2026 | Nicholas Maestas | TPST | Award | 140,000 | — | — |
| Mar 31, 2026 | Justin Trojanowski | TPST | Award | 22,000 | — | — |
| Mar 24, 2026 | Matthew Angel | TPST | Purchase | 231,482 | $2.16 | $500K |
33 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=TPST" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Tempest Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →